tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Merus NV (DE:2GH)
FRANKFURT:2GH
Germany Market
2GH
Merus
Overview
Analyst Forecasts
Dividends
Earnings
Financials
Statistics
New
Technical Analysis
Historical Prices
New
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
DE:2GH Chart

Merus (2GH) Stock News & Sentiment

Compare
1 Followers
Buy Rating Affirmed for Merus: Petosemtamab’s Potential in Metastatic HNSCC Market Despite Keytruda’s Perioperative Success
Premium
Ratings
Buy Rating Affirmed for Merus: Petosemtamab’s Potential in Metastatic HNSCC Market Despite Keytruda’s Perioperative Success
4d ago
MRUS
Positive Outlook for Merus: Anticipated ASCO Data Could Boost Competitive Position and Stock Performance
Premium
Ratings
Positive Outlook for Merus: Anticipated ASCO Data Could Boost Competitive Position and Stock Performance
8d ago
MRUS
Merus’s Strategic Positioning and Growth Potential Justifies Buy Rating
Premium
Ratings
Merus’s Strategic Positioning and Growth Potential Justifies Buy Rating
11d ago
MRUS
Merus’s Promising Position in Healthcare: Buy Rating Backed by Pivotal Studies and Upcoming Data Milestones
Premium
Ratings
Merus’s Promising Position in Healthcare: Buy Rating Backed by Pivotal Studies and Upcoming Data Milestones
24d ago
MRUS
Promising Outlook for Merus: Buy Rating Backed by Strong Clinical Trial Potential and Financial Stability
Premium
Ratings
Promising Outlook for Merus: Buy Rating Backed by Strong Clinical Trial Potential and Financial Stability
25d ago
MRUS
Buy Rating on Merus: Promising Potential of Petosemtamab in Combination with PD-1 Therapy for Head and Neck Cancer
Premium
Ratings
Buy Rating on Merus: Promising Potential of Petosemtamab in Combination with PD-1 Therapy for Head and Neck Cancer
1M ago
MRUS
Merus N.V. Reports 2024 Earnings and Clinical Progress
Premium
Company Announcements
Merus N.V. Reports 2024 Earnings and Clinical Progress
2M ago
MRUS
More DE:2GH News >

2GH News on the Web

Why Merus N.V.amp;#8217;s (MRUS) Stock Is Up 5.54%
AAII
Neutral
Strength Seen in BioMarin (BMRN): Can Its 6.3% Jump Turn into More Strength?
Zacks
Neutral
Analysts Conflicted on These Healthcare Names: PTC Therapeutics (PTCT), Radnet (RDNT) and Merus (MRUS)
TipRanks News
Neutral
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Teladoc (TDOC), Merus (MRUS) and Agilent (A)
TipRanks News
Neutral
Analyst Forecasts Just Became More Bearish On Merus N.V.
Yahoo Finance
Neutral
Merus (MRUS) Receives a Buy from Stifel Nicolaus
TipRanks News
Neutral
Merus N.V. (MRUS) Reports Q4 Loss, Lags Revenue Estimates
Zacks
Neutral
Merus Announces Financial Results for the Fourth Quarter and Full Year 2024 and Provides Business Update
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
DE:2GH
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:2GH’s Media Buzz Sentiment?
Currently, no data Available
What is DE:2GH’s weekly average amount of articles?
Currently, no data Available
What is DE:2GH’s News Sentiment?
59% of articles about DE:2GH were positive this week, compared to its sector average of 56%.
    Healthcare Stocks that are Trending in the News
    URGNUrogen Pharma
    SWTXSpringworks Therapeutics
    WGSGeneDx Holdings
    ENSGThe Ensign Group
    SRDXSurModics
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing